Abstract

Slices of rat substantia nigra were preloaded with tritiated γ-aminobutyrate (GABA) or dopamine (DA) and perfused with Krebs solution containing 5 μM aminooxyacetic acid or 10 μM nialamide to inhibit the catabolism of GABA and DA respectively. Repeated brief exposures to high potassium medium (+ 30 mM K + for 1 min) evoked a consistent pattern of calcium-dependent 3H efflux against which the effects of opiates (10–400 μM) were assessed. Opiate agonists inhibited K +-induced 3H-GABA efflux in the following decreasing order of potency : bremazocine > D-Ala 2-Met 5 -enkephalinamide (ENK) > SKF 10047 ⪢ morphine, consistent with the participation of κ,δ,σ and to a lesser extent μ opiate receptors respectively. Naloxone (1 μM) partially antagonised the response to morphine and ENK, while ICI 154129 attenuated ENK only. Save for a GABA-releasing action of SKF 10047 at high doses, none of the compounds altered basal outflow of 3H-GABA. Naloxone, in the dose range 10–400 μM, also significantly inhibited depolarisation-induced release of 3H-GABA. In parallel experiments none of the compounds tested were found to influence 3H-DA release in concentrations up to 40 μM, but thereafter suppressed K +-induced 3H-DA outflow indiscriminately. The results are discussed with reference to the possible mechanism(s) via which injected and endogenous opiates may affect motor performance by attenuating GABA transmission in the nigra.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.